Adjudin attenuates ischemic hippocampal damage in gerbils in association with increased SIRT3 immunoreactivity

Abstract Mitochondrial dysfunction and oxidative stress are major contributors to neuronal death following cerebral ischemia. Sirtuin 3 (SIRT3), a mitochondrial deacetylase, plays a critical role in regulating cellular metabolism and oxidative stress; however, its involvement in ischemia-induced neuronal injury remains incompletely understood. In the present study, we investigated temporal changes in SIRT3 immunoreactivity in the hippocampal CA1 region after transient forebrain ischemia and examined the neuroprotective effects of adjudin, a compound reported to upregulate SIRT3. In the sham-operated group, SIRT3 immunoreactivity was predominantly observed in hippocampal neurons, whereas its expression significantly decreased two days after ischemia. Adjudin treatment increased SIRT3 immunoreactivity in the CA1 region above vehicle levels following ischemia/reperfusion. Adjudin administration significantly attenuated ischemia-induced locomotor hyperactivity and reduced delayed neuronal death in the CA1 region. Furthermore, adjudin markedly suppressed ischemia-induced reactive oxygen species production and increased glutathione peroxidase immunoreactivity above the sham level. In parallel, adjudin treatment inhibited microglial activation and decreased the production of pro-inflammatory cytokines, including interleukin-1β and interleukin-6, in the hippocampus. Collectively, these findings show that the ischemia-induced reduction of SIRT3 immunoreactivity was accompanied by oxidative stress, neuroinflammation, and neuronal damage in the hippocampus, and that adjudin treatment increased SIRT3 immunoreactivity while attenuating these pathological changes. Because SIRT3 deacetylase activity and SIRT3 dependence were not directly assessed, the present data do not establish a SIRT3-dependent mechanism. These results nonetheless support further investigation of SIRT3 as a therapeutic target for ischemia-induced neuronal injury.

Authors

Institutions

Publication Details

Journal
BMC Neuroscience
Published
2026-09-30
DOI
https://doi.org/10.1186/s12868-026-01056-9
Primary Topic
Sirtuins and Resveratrol in Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Adjudin attenuates ischemic hippocampal damage in gerbils in association with increased SIRT3 immunoreactivity

Dae Won Kim, Woosuk Kim, Hyo Young Jung, Seung Myung Moon et al.
BMC Neuroscience
Sirtuins and Resveratrol in Medicine
article

Adjudin attenuates ischemic hippocampal damage in gerbils in association with increased SIRT3 immunoreactivity

Dae Won Kim, Woosuk Kim, Hyo Young Jung, Seung Myung Moon, Heekyeong Go, Dae Won Kim, Hyun Jung Kwon, Kyu Ri Hahn
article en

Abstract

Abstract Mitochondrial dysfunction and oxidative stress are major contributors to neuronal death following cerebral ischemia. Sirtuin 3 (SIRT3), a mitochondrial deacetylase, plays a critical role in regulating cellular metabolism and oxidative stress; however, its involvement in ischemia-induced neuronal injury remains incompletely understood. In the present study, we investigated temporal changes in SIRT3 immunoreactivity in the hippocampal CA1 region after transient forebrain ischemia and examined the neuroprotective effects of adjudin, a compound reported to upregulate SIRT3. In the sham-operated group, SIRT3 immunoreactivity was predominantly observed in hippocampal neurons, whereas its expression significantly decreased two days after ischemia. Adjudin treatment increased SIRT3 immunoreactivity in the CA1 region above vehicle levels following ischemia/reperfusion. Adjudin administration significantly attenuated ischemia-induced locomotor hyperactivity and reduced delayed neuronal death in the CA1 region. Furthermore, adjudin markedly suppressed ischemia-induced reactive oxygen species production and increased glutathione peroxidase immunoreactivity above the sham level. In parallel, adjudin treatment inhibited microglial activation and decreased the production of pro-inflammatory cytokines, including interleukin-1β and interleukin-6, in the hippocampus. Collectively, these findings show that the ischemia-induced reduction of SIRT3 immunoreactivity was accompanied by oxidative stress, neuroinflammation, and neuronal damage in the hippocampus, and that adjudin treatment increased SIRT3 immunoreactivity while attenuating these pathological changes. Because SIRT3 deacetylase activity and SIRT3 dependence were not directly assessed, the present data do not establish a SIRT3-dependent mechanism. These results nonetheless support further investigation of SIRT3 as a therapeutic target for ischemia-induced neuronal injury.

BMC Neuroscience
Seoul National University (KR), Hallym University (KR), Kangwon National University (KR), Chungnam National University (KR), Konkuk University (KR), Hallym University Kangnam Sacred Heart Hospital (KR), Research Institute for Veterinary Science (KR)
Good health and well-being
Openalex Percentile: Top 15%
Sirtuins and Resveratrol in Medicine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.